Regeneron Pharmaceuticals, Inc. Class Action Lawsuit
Robbins LLP is Investigating Allegations that Regeneron Therapeutics, Inc. (REGN) Misled Investors Regarding the Viability of its Phase III Fianlimab-Libtayo Study Robbins LLP informs stockholders that a class action was filed